Form D · Other Health Care

North Texas Renal Management XI, LLC

Dallas, TX · CIK 0001942847

Offering snapshot reported Jan 30, 2023 · SEC filing

Reported sold
$131K
Offering amount: $131K
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 1, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 30, 2023Initial$131,250No comparison9SEC filing
Aug 23, 2022Initial$639,474No comparison43SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-472137

Source: Form D, filed Jan 30, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jyothsna Kodali Director
Jyothsna M Kodali, M.D. Director
Daniel Richey Director
Daniel M Richey, D.O. Director
Joris M. Schuller Director
Joris M Schuller, Jr., M.D. Director
Anupkumar Shetty Director
Anupkumar Shetty, M.D. Director
Geoffrey Walker Director, Executive, Promoter
Geoffrey Walker, M.D. Director, Executive, Promoter

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1420 Viceroy Drive
Dallas, TX, 75235